Univ. of Washington spinout Icosavax raises $51M to fight viruses with computer-designed vaccines

This post was originally published on this site

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. (Icosavax Photo)

Seattle-based biotech startup Icosavax today scored $51 million in funding to create vaccines from artificial viruses. The Series A financing was led by Qiming Venture Partners USA along with Adams


Check out http://contacted.org